Heron Therapeutics logo
Heron Therapeutics HRTX
$ 1.25 2.93%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Heron Therapeutics Balance Sheet 2011-2024 | HRTX

Annual Balance Sheet Heron Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-22.8 M -7.17 M -80.1 M -83.5 M -52.1 M -27.3 M -116 M 39.5 M -73 M -71.1 M -71.3 M -53 M -17.9 M

Long Term Debt

2.8 M 5.5 M 8 M 14.6 M - - - 50 M - - - - -

Long Term Debt Current

3.08 M 2.69 M 2.42 M 3 M 1.93 M - - - - - - - -

Total Non Current Liabilities

- - - 14.6 M 12.2 M - - 50 M - - - - -

Total Current Liabilities

79.7 M 82.4 M 71.1 M 103 M 96.7 M 92 M 103 M 38.7 M 19.7 M 13.6 M 6.99 M 4.15 M 3.69 M

Total Liabilities

256 M 237 M 228 M 117 M 109 M 92 M 103 M 88.7 M 19.7 M 13.6 M 6.99 M 4.15 M 3.69 M

Deferred Revenue

- - - - - - 2.76 M 1.1 M - - - - -

Retained Earnings

-1.91 B -1.8 B -1.61 B -1.39 B -1.17 B -961 M -783 M -586 M -413 M -315 M -239 M -184 M -160 M

Total Assets

223 M 251 M 306 M 354 M 513 M 462 M 234 M 67.5 M 138 M 76.7 M 75.9 M 56 M 19.4 M

Cash and Cash Equivalents

28.7 M 15.4 M 90.5 M 105 M 71.9 M 31.8 M 145 M 13.4 M 75.2 M 72.7 M 72.3 M 53.5 M 18 M

Book Value

-34 M 13.6 M 77.6 M 236 M 404 M 370 M 131 M -21.3 M 118 M 63.1 M 68.9 M 51.8 M 15.8 M

Total Shareholders Equity

-34 M 13.6 M 77.6 M 236 M 404 M 370 M 131 M -21.3 M 118 M 63.1 M 68.9 M 51.8 M 15.8 M

All numbers in USD currency

Quarterly Balance Sheet Heron Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

522 K 1.29 M 2.04 M 3.54 M 4.16 M 4.83 M 5.5 M 6.15 M 6.78 M 7.39 M 8 M 12.2 M 13 M 13.8 M 14.6 M 14.6 M 14.6 M 14.6 M 12.2 M 12.2 M 12.2 M 12.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

261 M 256 M 252 M 257 M 241 M 232 M 237 M 250 M 266 M 250 M 228 M 234 M 244 M 115 M 117 M 117 M 117 M 117 M 109 M 109 M 109 M 109 M 92 M 92 M 92 M 92 M 103 M 78.1 M 73.3 M 87.4 M 88.7 M 88.7 M 88.7 M 88.7 M 19.7 M 19.7 M - - - - - - - - - - - - - 3.36 M 3.69 M 2.6 M 3.23 M -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - 2.76 M 5.56 M 2.76 M 2.76 M 1.1 M 1.1 M 1.1 M 1.1 M - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-1.92 B -1.92 B -1.91 B -1.9 B -1.87 B -1.83 B -1.8 B -1.78 B -1.73 B -1.68 B -1.61 B -1.56 B -1.51 B -1.45 B -1.39 B -1.39 B -1.39 B -1.39 B -1.17 B -1.17 B -1.17 B -1.17 B -961 M -961 M -961 M -961 M -783 M -783 M -783 M -783 M -586 M -586 M -586 M -586 M -413 M -413 M -413 M -413 M -315 M -315 M -315 M -315 M -239 M -239 M -239 M -239 M -184 M -184 M -184 M -184 M -160 M -160 M -160 M -160 M

Total Assets

221 M 218 M 218 M 229 M 201 M 221 M 251 M 272 M 244 M 274 M 306 M 352 M 404 M 311 M 354 M 354 M 354 M 354 M 513 M 513 M 513 M 513 M 462 M 462 M 462 M 462 M 234 M 234 M 234 M 234 M 67.5 M 67.5 M 67.5 M 67.5 M 138 M 138 M 138 M 138 M 76.7 M 76.7 M 76.7 M 76.7 M 75.9 M 75.9 M 75.9 M 75.9 M 56 M 56 M 56 M 56 M 19.4 M 19.4 M 19.4 M 19.4 M

Cash and Cash Equivalents

25.7 M 18.4 M 20.4 M 34.9 M 13.5 M 27.1 M 15.4 M 50.4 M 48.6 M 56.9 M 90.5 M 160 M 191 M 59.7 M 105 M 105 M 105 M 105 M 71.9 M 71.9 M 71.9 M 71.9 M 31.8 M 31.8 M 31.8 M 31.8 M 145 M 145 M 145 M 145 M 13.4 M 13.4 M 13.4 M 13.4 M 75.2 M 75.2 M 75.2 M 75.2 M 72.7 M 72.7 M 72.7 M 72.7 M 72.3 M 72.3 M 72.3 M 72.3 M 53.5 M 53.5 M 53.5 M 53.5 M 18 M 18 M 18 M 18 M

Book Value

-40 M -37.9 M -33.8 M -27.8 M -39.3 M -11.4 M 13.6 M 22.4 M -21.7 M 24 M 77.6 M 119 M 160 M 196 M 236 M 236 M 236 M 236 M 404 M 404 M 404 M 404 M 370 M 370 M 370 M 370 M 131 M 156 M 161 M 147 M -21.3 M -21.3 M -21.3 M -21.3 M 118 M 118 M 138 M 138 M 76.7 M 76.7 M 76.7 M 76.7 M 75.9 M 75.9 M 75.9 M 75.9 M 56 M 56 M 56 M 52.6 M 15.8 M 16.8 M 16.2 M 19.4 M

Total Shareholders Equity

-40 M -37.9 M -33.8 M -27.8 M -39.3 M -11.4 M 13.6 M 22.4 M -21.7 M 24 M 77.6 M 119 M 160 M 196 M 236 M 236 M 236 M 236 M 404 M 404 M 404 M 404 M 370 M 370 M 370 M 370 M 131 M 131 M 131 M 131 M -21.3 M -21.3 M -21.3 M -21.3 M 118 M 118 M 118 M 118 M 63.1 M 63.1 M 63.1 M 63.1 M 68.9 M 68.9 M 68.9 M 68.9 M 51.8 M 51.8 M 51.8 M 51.8 M 15.8 M 15.8 M 15.8 M 15.8 M

All numbers in USD currency